Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non–Small-Cell Lung Cancer Harboring <i>MET</i> Exon 14 Skipping
Xiuning Le(The University of Texas MD Anderson Cancer Center), John V. Heymach(The University of Texas MD Anderson Cancer Center), Marcelo V. Negrão(The University of Texas MD Anderson Cancer Center), David S. Hong(The University of Texas MD Anderson Cancer Center), Lingzhi Hong(The University of Texas MD Anderson Cancer Center), Stephen V. Liu(Georgetown University), Haley N. Kemp(The University of Texas MD Anderson Cancer Center), Dilafruz Juraeva(Merck KGaA, Darmstadt (Germany)), Anne S. Tsao(The University of Texas MD Anderson Cancer Center), Niamh Coleman(The University of Texas MD Anderson Cancer Center), Charles H. Hensel(The University of Texas at San Antonio Health Science Center), Jennifer Yen(Guardant (United States)), Christine Ciunci(University of Pennsylvania), Victoria M. Raymond(Guardant (United States)), Jianjun Zhang(The University of Texas MD Anderson Cancer Center), Rongrong Chen, Xuefeng Xia(Annoroad Gene Technology (China)), Paul K. Paik(Memorial Sloan Kettering Cancer Center), Juergen Scheuenpflug(Merck KGaA, Darmstadt (Germany)), Christopher Stroh(Universität Hamburg)
Cited by 21
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k